Targeting PARK7: Sodium 4-Phenylbutyrate shields endothelial cells from oxidative stress and GSDME-mediated Pyroptosis in acute lung injury
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.115386 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Jian Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai Respiratory Research Institute, Department of Pulmonary Medicine, Zhongshan Hospita…. Hauptthemen laut MEDLINE: Acute Lung Injury, Phenylbutyrates, Histone Deacetylase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghai Municipality Science and Technology Commission, Key Technologies Research and Development Program of Guangzhou, National Key Research and Development Program of China.
Abstract (Originalsprache)
The mechanisms of endothelial cell injury in acute lung injury (ALI) remain unclear, and effective interventional strategies targeting endothelial cells are limited. Sodium 4-phenylbutyrate (Na-PBA), a histone deacetylase inhibitor, can potentially reduce oxidative damage. Its effects on pyroptosis and its relationship with PARK7, a redox-regulating protein, remain unclear. Using a lipopolysaccharide (LPS)-induced ALI mouse model, we evaluated Na-PBA's effects on lung tissue damage, inflammatory markers, and endothelial pyroptosis. In vitro, human umbilical vein endothelial cells (HUVECs) were treated with LPS, Nigericin, and Na-PBA to assess pyroptosis and oxidative stress responses. RNA sequencing, immunoblotting, gene knockdown, and overexpression were utilized to explore molecular mechanisms. Na-PBA pretreatment alleviated lung injury, reduced pulmonary edema, and lowered inflammatory cytokines in LPS-ALI mice. It significantly decreased oxidative stress and pyroptosis of endothelial cells via the cytochrome c (Cyt c)-caspase9-caspase3-GSDME pathway in vivo and in vitro. Na-PBA pretreatment increased PARK7 expression in HUVECs. Na-PBA depended on PARK7 to protect against HUVEC injury and GSDME-mediated pyroptosis in vitro and relied on PARK7 expression in endothelial cells to mitigate ALI in vivo. Na-PBA upregulated PARK7 through HDAC inhibition, which could be amplified through a positive feedback loop involving NRF2. Finally, upregulation of PARK7 may alleviate downstream caspase activation and pyroptosis by stabilizing mitochondria and inhibiting Cyt c leakage from mitochondria. In conclusion, Na-PBA alleviates ALI by modulating oxidative stress and pyroptosis through the PARK7-dependent Cyt c-caspase9-caspase3-GSDME pathway. This study's results provide a novel therapeutic approach for mitigating endothelial cell injury in lung diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai Respiratory Research Institute, Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
- Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China.
- Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai Respiratory Research Institute, Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Shanghai Institute of Inf…
- Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai Respiratory Research Institute, Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Electronic address: wu.xu…
Förderung
- Shanghai Municipality Science and Technology Commission
- Key Technologies Research and Development Program of Guangzhou
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Xu, J., Wei, T., Wang, Y., Zhang, C., Chen, X., Li, Y., Song, J., Mao, W., Xu, Q., Wu, X., & Song, Y. (2025). Targeting PARK7: Sodium 4-Phenylbutyrate shields endothelial cells from oxidative stress and GSDME-mediated Pyroptosis in acute lung injury. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115386
Vancouver
Xu J, Wei T, Wang Y, Zhang C, Chen X, Li Y, et al. Targeting PARK7: Sodium 4-Phenylbutyrate shields endothelial cells from oxidative stress and GSDME-mediated Pyroptosis in acute lung injury. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115386
BibTeX
@article{Xu2025,
author = {Xu, Jian and Wei, Tianchang and Wang, Yuhan and Zhang, Cuiping and Chen, Xiaoyan and Li, Yufan and Song, Juan and Mao, Weiqi and Xu, Qingyuan and Wu, Xu and Song, Yuanlin},
title = {Targeting PARK7: Sodium 4-Phenylbutyrate shields endothelial cells from oxidative stress and GSDME-mediated Pyroptosis in acute lung injury},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.115386}
}
EUVIMED